Plain-English translation of NCT05921773 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to treat generalized anxiety disorder using a technology called functional near-infrared spectroscopy (fNIRS), which safely measures blood flow in the brain. Researchers will use artificial intelligence to identify patterns in your brain activity related to anxiety, then show you real-time feedback about those patterns while you practice mindfulness and cognitive therapy techniques. The goal is to help you learn to control anxiety-related brain activity and reduce your symptoms.
Current anxiety treatments don't work equally well for everyone, and many people don't complete treatment or have ongoing symptoms. This trial aims to create a more personalized approach by giving you direct, visual feedback about your own brain's anxiety patterns, which may make mindfulness training more effective and help you stay engaged in treatment.
You likely qualify if…
You likely don't qualify if…
If you join, you will come to the hospital 3 times a week for 4 weeks. During each visit, you'll wear a special headband with sensors that safely measure blood flow in your brain while you rest and complete some thinking tasks. You'll then receive real-time feedback (either actual or simulated) about your brain's anxiety patterns while practicing mindfulness exercises. The whole study unfolds over several years, starting with researchers mapping anxiety patterns in many people's brains, then testing whether the feedback system actually helps reduce anxiety in a larger group of patients like you.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
Taiwan